Infectious scleritis after retinal surgery.
OBJECTIVE
To report a series of patients in whom infectious scleritis developed after vitreoretinal surgery.


METHODS
Interventional case series of four patients.


METHODS
Medical records of patients at a single institution in whom infectious scleritis developed after vitreoretinal surgery were reviewed.


RESULTS
In three patients, infectious scleritis developed after 20-gauge pars plana vitrectomy, and in one patient, infectious scleritis developed after a scleral buckling procedure. Three cases were had positive culture results; the identified organisms were Pseudomonas aeruginosa in two cases and methicillin-resistant Staphylococcus aureus in one. The fourth patient did not have culture results but responded rapidly to empiric treatment with moxifloxacin. In one patient, surgically induced necrotizing scleritis subsequently developed.


CONCLUSIONS
Although infectious scleritis is an uncommon complication after vitreoretinal surgery, it should be a considered cause in patients with persistent postoperative pain and inflammation.
Rich
Ryan M
RM
Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA.
Smiddy
William E
WE
Davis
Janet L
JL
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012591:Scleral Buckling / Q000009:adverse effects*; D015423:Scleritis / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014792:Visual Acuity; D014821:Vitrectomy / Q000009:adverse effects*
D000900:Anti-Bacterial Agents